ARTICLE | Company News
Aphton seeking Swiss approval for G17DT
June 10, 2004 7:00 AM UTC
APHT said it began submitting regulatory documents to support Swiss approval of its G17DT as monotherapy to treat advanced pancreatic cancer in patients who are unable to tolerate or elect not to take...